Narcolepsy

Sleep Medicine Clinics

Volumn 7, Issue 2, 2012, Pages 263-281

  Overeem, Sebastiaan ^a,b   Reading, Paul ^c   Bassetti, Claudio L ^d,e  

^a RADBOUD UNIVERSITY   (Netherlands)

^b EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

^e REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

Cataplexy; Excessive daytime sleepiness; Hypersomnia; Hypocretin; Narcolepsy; Orexin

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; OREXIN; PURINERGIC P2Y11 RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA 2; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANXIETY DISORDER; ARTICLE; AUTOIMMUNITY; AUTOSOMAL RECESSIVE INHERITANCE; CATAPLEXY; CAUCASIAN; CHILDHOOD DISEASE; CLINICAL FEATURE; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EXCESSIVE DAYTIME SLEEPINESS; FINLAND; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HALLUCINATION; HLA TYPING; HUMAN; HYPOCRETIN DEFICIENCY SYNDROME; INCIDENCE; ISRAEL; JAPAN; MEMORY DISORDER; MENTAL DISEASE; MONOZYGOTIC TWINS; MOOD DISORDER; MULTIPLE SLEEP LATENCY TEST; MUSCLE HYPOTONIA; NARCOLEPSY; NONHUMAN; OBESITY; PAIN; PARASOMNIA; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; REFERENCE VALUE; REM SLEEP; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SLEEP DISORDER; SLEEP PARAMETERS; SWEDEN; WESTERN HEMISPHERE;

EID: 84861620370     PISSN: 1556407X     EISSN: 15564088     Source Type: Journal    
DOI: 10.1016/j.jsmc.2012.03.013     Document Type: Review

References (158)

1. E. Mignot A hundred years of narcolepsy research Arch Ital Biol 139 2001 207 220
2. Y. Dauvilliers, I. Arnulf, and E. Mignot Narcolepsy with cataplexy Lancet 369 2007 499 511
3. C. Sturzenegger, and C. Bassetti The clinical spectrum of narcolepsy with cataplexy: a reappraisal J Sleep Res 13 2004 395 406
4. S. Nishino Hypothalamus, hypocretins/orexin, and vigilance control Handb Clin Neurol 99 2011 765 782
5. R. Dodel, H. Peter, and A. Spottke Health-related quality of life in patients with narcolepsy Sleep Med 8 2007 733 741
6. L. Vignatelli, G. Plazzi, and F. Peschechera A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy Sleep Med 12 2011 19 23
7. C. Westphal Eigenthümliche mit Einschlafen verbundene Anfälle Arch Psychiatr Nervenkr 7 1877 631 635
8. J.B. Gélineau De la narcolepsie Gaz Hôp (Paris) 53 1880 626 628
9. S. Overeem, E. Mignot, and J.G. van Dijk Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives J Clin Neurophysiol 18 2001 78 105
10. R.E. Yoss, and D.D. Daly Criteria for the diagnosis of the narcoleptic syndrome Proc Staff Meet Mayo Clin 32 1957 320 328
11. S.W. Kok, S. Overeem, and T.L. Visscher Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity Obes Res 11 2003 1147 1154
12. H.A. Fortuyn, M.A. Lappenschaar, and J.W. Furer Anxiety and mood disorders in narcolepsy: a case-control study Gen Hosp Psychiatry 32 2010 49 56
13. H.A. Fortuyn, S. Swinkels, and J. Buitelaar High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study Sleep 31 2008 335 341
14. W.T. Longstreth Jr., T.D. Koepsell, and T.G. Ton The epidemiology of narcolepsy Sleep 30 2007 13 26
15. M.M. Ohayon, R.G. Priest, and J. Zulley Prevalence of narcolepsy symptomatology and diagnosis in the European general population Neurology 58 2002 1826 1833
16. C. Hublin, J. Kaprio, and M. Partinen The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort Ann Neurol 35 1994 709 716
17. P. Lavie, and R. Peled Narcolepsy is a rare disease in Israel Sleep 10 1987 608 609
18. Y. Honda Census of narcolepsy, cataplexy and sleep life among teenagers in Fujisawa city Sleep Res 8 1979 191
19. M.H. Silber, L.E. Krahn, and E.J. Olson The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study Sleep 25 2002 197 202
20. E. Morrish, M.A. King, and I.E. Smith Factors associated with a delay in the diagnosis of narcolepsy Sleep Med 5 2004 37 41
21. Y. Dauvilliers, J. Montplaisir, and N. Molinari Age at onset of narcolepsy in two large populations of patients in France and Quebec Neurology 57 2001 2029 2033
22. G. Plazzi, F. Pizza, and V. Palaia Complex movement disorders at disease onset in childhood narcolepsy with cataplexy Brain 134 2011 3480 3492
23. M.M. Ohayon, L. Ferini-Strambi, and G. Plazzi How age influences the expression of narcolepsy J Psychosom Res 59 2005 399 405
24. M.M. Mitler, B.G. Boysen, and L. Campbell Narcolepsy-cataplexy in a female dog Exp Neurol 45 1974 332 340
25. A.S. Foutz, M.M. Mitler, and L.L. Cavalli-Sforza Genetic factors in canine narcolepsy Sleep 1 1979 413 421
26. L. Lin, J. Faraco, and R. Li The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene Cell 98 1999 365 376
27. R.M. Chemelli, J.T. Willie, and C.M. Sinton Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation Cell 98 1999 437 451
28. S. Nishino, and E. Mignot Pharmacological aspects of human and canine narcolepsy Prog Neurobiol 52 1997 27 78
29. A.K. De La Herran-Arita, V.C. Zomosa-Signoret, and D.A. Millan-Aldaco Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice Neuroscience 183 2011 134 143
30. D. Gerashchenko, M.D. Kohls, and M. Greco Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat J Neurosci 21 2001 7273 7283
31. M. Mieda, E. Hasegawa, and Y.Y. Kisanuki Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep J Neurosci 31 2011 6518 6526
32. J.T. Willie, R.M. Chemelli, and C.M. Sinton Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes Neuron 38 2003 715 730
33. J. Hara, C.T. Beuckmann, and T. Nambu Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity Neuron 30 2001 345 354
34. T.E. Scammell, J.T. Willie, and C. Guilleminault A consensus definition of cataplexy in mouse models of narcolepsy Sleep 32 2009 111 116
35. S. Nishino, B. Ripley, and S. Overeem Hypocretin (orexin) deficiency in human narcolepsy Lancet 355 2000 39 40
36. S. Nishino, B. Ripley, and S. Overeem Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy Ann Neurol 50 2001 381 388
37. C. Bassetti, M. Gugger, and M. Bischof The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A) Sleep Med 4 2003 7 12
38. T. Kanbayashi, Y. Inoue, and S. Chiba CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia J Sleep Res 11 2002 91 93
39. L.E. Krahn, V.S. Pankratz, and L. Oliver Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status Sleep 25 2002 733 736
40. E. Mignot, G.J. Lammers, and B. Ripley The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias Arch Neurol 59 2002 1553 1562
41. B. Ripley, S. Overeem, and N. Fujiki CSF hypocretin/orexin levels in narcolepsy and other neurological conditions Neurology 57 2001 2253 2258
42. S. Nishino, and T. Kanbayashi Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system Sleep Med Rev 9 2005 269 310
43. C.R. Baumann, R. Stocker, and H.G. Imhof Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury Neurology 65 2005 147 149
44. T. Kanbayashi, H. Ishiguro, and R. Aizawa Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barre syndrome Psychiatry Clin Neurosci 56 2002 273 274
45. S. Nishino, T. Kanbayashi, and N. Fujiki CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies Neurology 61 2003 823 825
46. S. Overeem, J. Dalmau, and L. Bataller Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis Neurology 62 2004 138 140
47. C. Peyron, J. Faraco, and W. Rogers A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains Nat Med 6 2000 991 997
48. T.C. Thannickal, R.Y. Moore, and R. Nienhuis Reduced number of hypocretin neurons in human narcolepsy Neuron 27 2000 469 474
49. T.C. Thannickal, J.M. Siegel, and R. Nienhuis Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy Brain Pathol 13 2003 340 351
50. A.M. Blouin, T.C. Thannickal, and P.F. Worley Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy Neurology 65 2005 1189 1192
51. A. Crocker, R.A. Espana, and M. Papadopoulou Concomitant loss of dynorphin, NARP, and orexin in narcolepsy Neurology 65 2005 1184 1188
52. D. Chabas, S. Taheri, and C. Renier The genetics of narcolepsy Annu Rev Genomics Hum Genet 4 2003 459 483
53. E. Mignot Genetic and familial aspects of narcolepsy Neurology 50 1998 S16 S22
54. Y. Dauvilliers, S. Maret, and C. Bassetti A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1 Neurology 62 2004 2137 2138
55. M. Honda, Y. Honda, and S. Uchida Monozygotic twins incompletely concordant for narcolepsy Biol Psychiatry 49 2001 943 947
56. R. Khatami, S. Maret, and E. Werth Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway Lancet 363 2004 1199 1200
57. M. Partinen, C. Hublin, and J. Kaprio Twin studies in narcolepsy Sleep 17 1994 S13 S16
58. T. Juji, M. Satake, and Y. Honda HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive Tissue Antigens 24 1984 316 319
59. E. Mignot, R. Hayduk, and J. Black HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients Sleep 20 1997 1012 1020
60. E. Mignot, A. Kimura, and A. Lattermann Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy Tissue Antigens 49 1997 329 341
61. H. Hor, Z. Kutalik, and Y. Dauvilliers Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy Nat Genet 42 2010 786 789
62. J. Hallmayer, J. Faraco, and L. Lin Narcolepsy is strongly associated with the T-cell receptor alpha locus Nat Genet 41 2009 708 711
63. H. Hohjoh, T. Nakayama, and J. Ohashi Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy Tissue Antigens 54 1999 138 145
64. H. Hohjoh, N. Terada, and M. Kawashima Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy Tissue Antigens 56 2000 446 448
65. B.R. Kornum, M. Kawashima, and J. Faraco Common variants in P2RY11 are associated with narcolepsy Nat Genet 43 2011 66 71
66. S. Overeem, J.L. Black 3rd, and G.J. Lammers Narcolepsy: immunological aspects Sleep Med Rev 12 2008 95 107
67. A. Fontana, H. Gast, and W. Reith Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain 133 2010 1300 1311
68. T.E. Scammell The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy Sleep 29 2006 601 602
69. S. Overeem, J.J. Verschuuren, and R. Fronczek Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy J Neuroimmunol 174 2006 187 191
70. J.L. Black 3rd, L.E. Krahn, and V.S. Pankratz Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602 Sleep 25 2002 719 723
71. J.L. Black 3rd, M.H. Silber, and L.E. Krahn Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy Biol Psychiatry 58 2005 504 509
72. J.L. Black 3rd, R.K. Avula, and D.L. Walker HLA DQB1*0602 positive narcoleptic subjects with cataplexy have CSF lgG reactive to rat hypothalamic protein extract Sleep 28 2005 1191 1192
73. V. Cvetkovic-Lopes, L. Bayer, and S. Dorsaz Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients J Clin Invest 120 2010 713 719
74. M. Kawashima, L. Lin, and S. Tanaka Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy Sleep 33 2010 869 874
75. H. Toyoda, S. Tanaka, and T. Miyagawa Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy Sleep 33 2010 875 878
76. A. Aran, L. Lin, and S. Nevsimalova Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset Sleep 32 2009 979 983
77. W.T. Longstreth Jr., T.G. Ton, and T.D. Koepsell Narcolepsy and streptococcal infections Sleep 32 2009 1548
78. Y. Dauvilliers Follow-up of four narcolepsy patients treated with intravenous immunoglobulins Ann Neurol 60 2006 153
79. Y. Dauvilliers, B. Carlander, and F. Rivier Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset Ann Neurol 56 2004 905 908
80. M. Lecendreux, S. Maret, and C. Bassetti Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy J Sleep Res 12 2003 347 348
81. R. Fronczek, J. Verschuuren, and G.J. Lammers Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy J Neurol 254 2007 1607 1608
82. G. Plazzi, F. Poli, and C. Franceschini Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy J Neurol 255 2008 1549 1554
83. P.O. Valko, R. Khatami, and C.R. Baumann No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy J Neurol 255 2008 1900 1903
84. C. Bardage, I. Persson, and A. Ortqvist Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden BMJ 343 2011 d5956
85. Y. Dauvilliers, J. Montplaisir, and V. Cochen Post-H1N1 narcolepsy-cataplexy Sleep 33 2010 1428 1430
86. J. Zarocostas WHO backs further probes into possible link between H1N1 vaccine and narcolepsy in children BMJ 342 2011 d909
87. F. Han, L. Lin, and S.C. Warby Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China Ann Neurol 70 2011 410 417
88. L. Bayer, E. Eggermann, and M. Serafin Orexins (hypocretins) directly excite tuberomammillary neurons Eur J Neurosci 14 2001 1571 1575
89. C. Peyron, D.K. Tighe, and A.N. van den Pol Neurons containing hypocretin (orexin) project to multiple neuronal systems J Neurosci 18 1998 9996 10015
90. C.B. Saper, T.C. Chou, and T.E. Scammell The sleep switch: hypothalamic control of sleep and wakefulness Trends Neurosci 24 2001 726 731
91. C.G. Diniz Behn, E.B. Klerman, and T. Mochizuki Abnormal sleep/wake dynamics in orexin knockout mice Sleep 33 2010 297 306
92. T. Mochizuki, A. Crocker, and S. McCormack Behavioral state instability in orexin knock-out mice J Neurosci 24 2004 6291 6300
93. R. Broughton, W. Dunham, and J. Newman Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls Electroencephalogr Clin Neurophysiol 70 1988 473 481
94. G.J. Lammers, S. Overeem, and M.A. Tijssen Effects of startle and laughter in cataplectic subjects: a neurophysiological study between attacks Clin Neurophysiol 111 2000 1276 1281
95. S. Overeem, G.J. Lammers, and J.G. van Dijk Weak with laughter Lancet 354 1999 838
96. S. Overeem, R. Reijntjes, and W. Huyser Corticospinal excitability during laughter: implications for cataplexy and the comparison with REM sleep atonia J Sleep Res 13 2004 257 264
97. S. Overeem, G.J. Lammers, and J.G. van Dijk Cataplexy: 'tonic immobility' rather than 'REM-sleep atonia'? Sleep Med 3 2002 471 477
98. B.Y. Mileykovskiy, L.I. Kiyashchenko, and J.M. Siegel Behavioral correlates of activity in identified hypocretin/orexin neurons Neuron 46 2005 787 798
99. Y. Hishikawa, and T. Shimizu Physiology of REM sleep, cataplexy, and sleep paralysis Adv Neurol 67 1995 245 271
100. R. Poryazova, B. Schnepf, and E. Werth Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy Sleep 32 2009 607 613
101. S. Schwartz, A. Ponz, and R. Poryazova Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy Brain 131 2008 514 522
102. G. Plazzi, L. Serra, and R. Ferri Nocturnal aspects of narcolepsy with cataplexy Sleep Med Rev 12 2008 109 128
103. J. Mullington, and R. Broughton Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy Sleep 16 1993 444 456
104. American Academy of Sleep Medicine The International Classification of Sleep Disorders: diagnostic and coding manual 2nd edition 2005 AASM Chicago
105. S. Anic-Labat, C. Guilleminault, and H.C. Kraemer Validation of a cataplexy questionnaire in 983 sleep-disorders patients Sleep 22 1999 77 87
106. C. Guilleminault, and M. Gelb Clinical aspects and features of cataplexy Adv Neurol 67 1995 65 77
107. S. Overeem, S.J. van Nues, and W.L. van der Zande The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency Sleep Med 12 2011 12 18
108. M. Gelb, C. Guilleminault, and H. Kraemer Stability of cataplexy over several months-information for the design of therapeutic trials Sleep 17 1994 265 273
109. R. Poryazova, M. Siccoli, and E. Werth Unusually prolonged rebound cataplexy after withdrawal of fluoxetine Neurology 65 2005 967 968
110. L. Serra, P. Montagna, and E. Mignot Cataplexy features in childhood narcolepsy Mov Disord 23 2008 858 865
111. K. Dhondt, H. Verhelst, and D. Pevernagie Childhood narcolepsy with partial facial cataplexy: a diagnostic dilemma Sleep Med 10 2009 797 798
112. R. Peraita-Adrados, J.J. Garcia-Penas, and L. Ruiz-Falco Clinical, polysomnographic and laboratory characteristics of narcolepsy-cataplexy in a sample of children and adolescents Sleep Med 12 2011 24 27
113. H.A. Fortuyn, G.A. Lappenschaar, and F.J. Nienhuis Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia Gen Hosp Psychiatry 31 2009 146 154
114. A.B. Douglass, P. Hays, and F. Pazderka Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy J Nerv Ment Dis 179 1991 12 17 [discussion: 8]
115. J. Montplaisir, M. Billiard, and S. Takahashi Twenty-four-hour recording in REM-narcoleptics with special reference to nocturnal sleep disruption Biol Psychiatry 13 1978 73 89
116. J. Montplaisir, and R. Godbout Nocturnal sleep of narcoleptic patients: revisited Sleep 9 1986 159 161
117. R. Broughton, W. Dunham, and M. Weisskopf Night sleep does not predict day sleep in narcolepsy Electroencephalogr Clin Neurophysiol 91 1994 67 70
118. S. Nightingale, J.C. Orgill, and I.O. Ebrahim The association between narcolepsy and REM behavior disorder (RBD) Sleep Med 6 2005 253 258
119. C.H. Schenck, and M.W. Mahowald Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder Ann Neurol 32 1992 3 10
120. R. Fronczek, H.A. Middelkoop, and J.G. van Dijk Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART) Sleep 29 2006 187 191
121. M. Aguirre, R. Broughton, and D. Stuss Does memory impairment exist in narcolepsy-cataplexy? J Clin Exp Neuropsychol 7 1985 14 24
122. L.E. Daniels Narcolepsy Medicine 13 1934 1 122
123. N. Dahmen, J. Bierbrauer, and M. Kasten Increased prevalence of obesity in narcoleptic patients and relatives Eur Arch Psychiatry Clin Neurosci 251 2001 85 89
124. A. Schuld, J. Hebebrand, and F. Geller Increased body-mass index in patients with narcolepsy Lancet 355 2000 1274 1275
125. G.J. Lammers, H. Pijl, and J. Iestra Spontaneous food choice in narcolepsy Sleep 19 1996 75 76
126. I. Arnulf, L. Lin, and J. Zhang CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency? Sleep 29 2006 1017 1024
127. N. Dahmen, A. Engel, and J. Helfrich Peripheral leptin levels in narcoleptic patients Diabetes Technol Ther 9 2007 348 353
128. S.W. Kok, A.E. Meinders, and S. Overeem Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans J Clin Endocrinol Metab 87 2002 805 809
129. S. Overeem, S.W. Kok, and G.J. Lammers Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events Am J Physiol Endocrinol Metab 284 2003 E641 E647
130. A. Schuld, W.F. Blum, and M. Uhr Reduced leptin levels in human narcolepsy Neuroendocrinology 72 2000 195 198
131. Y. Dauvilliers, J. Paquereau, and H. Bastuji Psychological health in central hypersomnias: the French Harmony study J Neurol Neurosurg Psychiatry 80 2009 636 641
132. A. Kales, C.R. Soldatos, and E.O. Bixler Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology Arch Neurol 39 1982 169 171
133. A. Vourdas, J.M. Shneerson, and C.A. Gregory Narcolepsy and psychopathology: is there an association? Sleep Med 3 2002 353 360
134. A. Ponz, R. Khatami, and R. Poryazova Reduced amygdala activity during aversive conditioning in human narcolepsy Ann Neurol 67 2010 394 398
135. H.A. Droogleever Fortuyn, R. Fronczek, and M. Smitshoek Severe fatigue in narcolepsy with cataplexy J Sleep Res 21 2 2012 163 169
136. P.O. Valko, C.L. Bassetti, and K.E. Bloch Validation of the fatigue severity scale in a Swiss cohort Sleep 31 2008 1601 1607
137. D. Chabas, C. Foulon, and J. Gonzalez Eating disorder and metabolism in narcoleptic patients Sleep 30 2007 1267 1273
138. R. Poryazova, R. Khatami, and E. Werth Weak with sex: sexual intercourse as a trigger for cataplexy J Sex Med 6 2009 2271 2277
139. W.A. Broughton, and R.J. Broughton Psychosocial impact of narcolepsy Sleep 17 1994 S45 S49
140. A.J. Campbell, T.L. Signal, and K.M. O'Keeffe Narcolepsy in New Zealand: pathway to diagnosis and effect on quality of life N Z Med J 124 2011 51 61
141. A. David, F. Constantino, and J.M. Santos Health-related quality of life in Portuguese patients with narcolepsy Sleep Med 13 3 2012 273 277
142. S. Ervik, M. Abdelnoor, and M.S. Heier Health-related quality of life in narcolepsy Acta Neurol Scand 114 2006 198 204
143. L. Vignatelli, R. D'Alessandro, and P. Mosconi Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey Sleep Med 5 2004 467 475
144. R.J. Broughton, A. Guberman, and J. Roberts Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study Epilepsia 25 1984 423 433
145. M.R. Littner, C. Kushida, and M. Wise Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test Sleep 28 2005 113 121
146. G.J. Lammers, and J.G. van Dijk The multiple sleep latency test: a paradoxical test? Clin Neurol Neurosurg 94 Suppl 1992 S108 S110
147. M.S. Aldrich, R.D. Chervin, and B.A. Malow Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy Sleep 20 1997 620 629
148. C. Bishop, L. Rosenthal, and T. Helmus The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness Sleep 19 1996 727 730
149. J. Arii, T. Kanbayashi, and Y. Tanabe CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders Neurology 63 2004 2440 2442
150. M.S. Heier, T.S. Jansson, and K.M. Gautvik Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy J Clin Sleep Med 7 2011 653 658
151. H. Kubota, T. Kanbayashi, and Y. Tanabe Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children Sleep 26 2003 555 557
152. H. Tsukamoto, T. Ishikawa, and Y. Fujii Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy Neuropediatrics 33 2002 51 52
153. C.R. Baumann, and C.L. Bassetti Hypocretins (orexins) and sleep-wake disorders Lancet Neurol 4 2005 673 682
154. L. Lin, C. Bassetti, and G.J. Lammers Guidelines for the appropriate use of CSF measurements to diagnose narcolepsy C. Bassetti, M. Billiard, E. Mignot, Narcolepsy and Hypersomnia 2007 Informa Health Care New York 663 671
155. I. Marti, P.O. Valko, and R. Khatami Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome Sleep Med 10 2009 1146 1150
156. A. Sadeh The role and validity of actigraphy in sleep medicine: an update Sleep Med Rev 15 2011 259 267
157. M.S. Aldrich The clinical spectrum of narcolepsy and idiopathic hypersomnia Neurology 46 1996 393 401
158. M.H. Silber, L.E. Krahn, and E.J. Olson Diagnosing narcolepsy: validity and reliability of new diagnostic criteria Sleep Med 3 2002 109 113